Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Platinum-based or taxane chemotherapy drugs appear to ... to be caused by chemo drug damage that disrupts or rewires normal nerve signaling, resulting in persistent pain, researchers said.

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...